Your session is about to expire
← Back to Search
N/A
Peanuts for Cognitive Function
N/A
Waitlist Available
Led By Sujatha Rajaram, PhD
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Two cardiovascular risk factors
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Study Summary
This trial will study whether giving peanuts to older adults with memory complaints will improve their task-related brain activation and cognitive functions.
Who is the study for?
This trial is for non-demented elderly individuals aged 60-80 with memory complaints and at least two cardiovascular risk factors. They must have maintained a stable weight for the past six months. People with peanut allergies, smokers, those with certain metabolic or neuropsychological disorders, or who can't get an MRI are excluded.Check my eligibility
What is being tested?
The study investigates how regular peanut consumption affects brain function and cognition in older adults. Participants will add peanuts to their usual diet and undergo tests to measure changes in cognitive performance and brain activation.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include digestive discomfort due to increased fiber intake from peanuts, possible allergic reactions if participants were unaware of their sensitivity, and general dietary intolerance issues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have two risk factors for heart disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
changes from baseline in Brian activation
changes from baseline serum markers of inflammation
Secondary outcome measures
Change in serum brain-derived neurotrophic factor (pg/mL)
changes from baseline in global cognitive composite score
Trial Design
2Treatment groups
Active Control
Group I: Peanut GroupActive Control1 Intervention
Peanuts: 2-3 ounces per day to replace 20% of daily energy intake
Group II: Control GroupActive Control1 Intervention
Habitual diet abstain from eating peanuts
Find a Location
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,928 Total Patients Enrolled
1 Trials studying Cognition
54 Patients Enrolled for Cognition
The Peanut InstituteOTHER
5 Previous Clinical Trials
244 Total Patients Enrolled
Sujatha Rajaram, PhDPrincipal InvestigatorLoma Linda University
2 Previous Clinical Trials
106 Total Patients Enrolled
1 Trials studying Cognition
54 Patients Enrolled for Cognition
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have noticed problems with my memory.You are a smoker.I am between 60 and 80 years old and do not have dementia.I have two risk factors for heart disease.You are allergic to peanuts.I have a hormone, metabolism, or brain function disorder.You eat more than 3 servings of nuts (including peanuts) per week.
Research Study Groups:
This trial has the following groups:- Group 1: Peanut Group
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger